712 related articles for article (PubMed ID: 34289037)
1. Emerging neurotropic features of SARS-CoV-2.
Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
[TBL] [Abstract][Full Text] [Related]
2. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
Zhou Z; Kang H; Li S; Zhao X
J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
[TBL] [Abstract][Full Text] [Related]
3. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
4. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.
Johansson A; Mohamed MS; Moulin TC; Schiöth HB
J Neuroimmunol; 2021 Sep; 358():577658. PubMed ID: 34304141
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
Front Immunol; 2021; 12():674922. PubMed ID: 34040615
[TBL] [Abstract][Full Text] [Related]
6. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and Neurology: An Emerging Association.
Gupta A; Yadav P; Kumar D
Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
[TBL] [Abstract][Full Text] [Related]
8. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
9. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.
Xu Y; Zhuang Y; Kang L
Med Sci Monit; 2021 Jun; 27():e932962. PubMed ID: 34145211
[TBL] [Abstract][Full Text] [Related]
10. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
[TBL] [Abstract][Full Text] [Related]
11. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
12. Neurological Involvements of SARS-CoV2 Infection.
Gasmi A; Tippairote T; Mujawdiya PK; Gasmi Benahmed A; Menzel A; Dadar M; Bjørklund G
Mol Neurobiol; 2021 Mar; 58(3):944-949. PubMed ID: 33064267
[TBL] [Abstract][Full Text] [Related]
13. Does COVID-19 contribute to development of neurological disease?
Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
[TBL] [Abstract][Full Text] [Related]
14. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses.
Hu J; Jolkkonen J; Zhao C
Neurosci Biobehav Rev; 2020 Dec; 119():184-193. PubMed ID: 33091416
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
[TBL] [Abstract][Full Text] [Related]
16. Neurological complications and infection mechanism of SARS-COV-2.
Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
[TBL] [Abstract][Full Text] [Related]
17. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
[TBL] [Abstract][Full Text] [Related]
18. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
19. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.
Roy D; Ghosh R; Dubey S; Dubey MJ; Benito-León J; Kanti Ray B
Can J Neurol Sci; 2021 Jan; 48(1):9-24. PubMed ID: 32753076
[TBL] [Abstract][Full Text] [Related]
20. Neurological manifestations of coronavirus disease 2019: exploring past to understand present.
Desai I; Manchanda R; Kumar N; Tiwari A; Kumar M
Neurol Sci; 2021 Mar; 42(3):773-785. PubMed ID: 33428055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]